Internal Medicine, Pulmonary Disease · Layton, UT
NPI
1265418024
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2121 N 1700 W
Layton, UT, 84041
Phone (801) 773-4840
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,216 services
Medicare patients, 2024
619
Average age 74
Drug cost, 2024
$2.1M
1,253 prescriptions
Company payments, 2025
$2,353
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary J Alexander was code 94762 (pulmonary), 304 times for 270 patients. In total Gary J Alexander billed 1,216 services in 38 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94762 Pulmonary | Office | 304 | 270 | $16.36 | $4,974 |
| 99213 Office E&M - Established | Office | 237 | 144 | $60.04 | $14K |
| 95811 Sleep Study | Office | 125 | 111 | $449.24 | $56K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 94 | 94 | $65.52 | $6,159 |
| 94060 Pulmonary Function Testing | Facility | 94 | 94 | $7.41 | $697 |
| 94729 Pulmonary Function Testing | Facility | 91 | 91 | $6.42 | $584 |
| 94727 Pulmonary Function Testing | Facility | 90 | 90 | $8.64 | $778 |
| 95810 Sleep Study | Office | 65 | 65 | $424.61 | $28K |
| 71046 X-ray - Chest | Office | 32 | 30 | $22.55 | $722 |
By year: 2022 $139K for 2,246 services; 2023 $145K for 1,953 services; 2024 $115K for 1,216 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 12 | $7.36 | $110 |
Medicare prescription drug claims, 2024
In 2024, the drug Gary J Alexander prescribed most often to Medicare patients was Montelukast Sodium, with 181 prescriptions and refills. In total Gary J Alexander wrote 1,253 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 181 | 516 | 58 | $2,670 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 72 | 115 | 16 | $72K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 65 | 86 | 36 | $2,138 |
| Azithromycin Generic | 54 | 56 | 32 | $263 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 45 | 77 | 15 | $47K |
| Prednisone Generic | 41 | 52 | 19 | $92.28 |
| Symbicort Budesonide/Formoterol Fumarate | 36 | 74 | 13 | $17K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 35 | 59 | 12 | $5,509 |
| Alprazolam Generic | 28 | 28 | Under 11 | $84.69 |
| Zemaira Alpha-1-Proteinase Inhibitor | 26 | 26 | Under 11 | $299K |
| Adempas Riociguat | 24 | 24 | Under 11 | $337K |
| Opsumit Macitentan | 23 | 31 | Under 11 | $392K |
| Amoxicillin Generic | 21 | 21 | Under 11 | $54.54 |
| Doxycycline Hyclate Generic | 20 | 23 | 14 | $451 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 19 | 33 | Under 11 | $4,281 |
Brand drugs: 490 claims; generic drugs: 763 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary J Alexander $2,353 ($2,353 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $520.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $520 |
| Inspire Medical Systems, Inc. INSP | 20 | $388 |
| GlaxoSmithKline, LLC. GSK | 13 | $197 |
| Viatris Specialty LLC | 13 | $171 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $154 |
| Axsome Therapeutics, Inc. AXSM | 5 | $103 |
| Grifols USA, LLC | 4 | $85.13 |
| Verona Pharma, Inc. VRNA | 4 | $82.08 |
| Harmony Biosciences LLC HRMY | 4 | $69.85 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $60.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.